Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pier Giovanni Baraldi

Showing results (11-20 of 159) with videos related to

Pageof 16
Sort By:
Bioorganic & Medicinal Chemistry|November 4, 2006
Hybrid molecules between distamycin A and active moieties of antitumor agentsPier Giovanni Baraldi, Delia Preti, Francesca Fruttarolo, et al.
Purinergic Signalling|April 30, 2008
Recent improvements in the development of A(2B) adenosine receptor agonistsPier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, Francesca Fruttarolo, et al.
Purinergic Signalling|February 3, 2009
Recent improvements in the development of A(2B) adenosine receptor agonistsPier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, Francesca Fruttarolo, et al.
Future Medicinal Chemistry|July 7, 2015
Current status of A1 adenosine receptor allosteric enhancersRomeo Romagnoli, Pier Giovanni Baraldi, Allan R Moorman, et al.
Bioorganic & Medicinal Chemistry|March 5, 2003
Synthesis and growth inhibition activity of alpha-bromoacrylic heterocyclic and benzoheterocyclic derivatives of distamycin A modified on the amidino moietyPier Giovanni Baraldi, Italo Beria, Paolo Cozzi, et al.
Medicinal Research Reviews|March 31, 2015
History and perspectives of A2A adenosine receptor antagonists as potential therapeutic agentsDelia Preti, Pier Giovanni Baraldi, Allan R Moorman, et al.
European Journal of Medicinal Chemistry|July 5, 2015
Design, synthesis and antiproliferative activity of novel heterobivalent hybrids based on imidazo[2,1-b][1,3,4]thiadiazole and imidazo[2,1-b][1,3]thiazole scaffoldsRomeo Romagnoli, Pier Giovanni Baraldi, Filippo Prencipe, et al.
Mini Reviews in Medicinal Chemistry|January 20, 2009
alpha-halogenoacrylic derivatives of antitumor agentsRomeo Romagnoli, Pier Giovanni Baraldi, Olga Cruz-Lopez, et al.
Chemmedchem|August 12, 2009
alpha-Bromoacrylamido N-substituted isatin derivatives as potent inducers of apoptosis in human myeloid leukemia cellsRomeo Romagnoli, Pier Giovanni Baraldi, Olga Cruz-Lopez, et al.
Journal of Biomedical Science|October 18, 2005
N-Arylpiperazine modified analogues of the P2X7 receptor KN-62 antagonist are potent inducers of apoptosis of human primary osteoclastsLetizia Penolazzi, Ercolina Bianchini, Elisabetta Lambertini, et al.
Pageof 16

Showing results (11-20 of 159) with videos related to

Sort By:
Pageof 16
Bioorganic & Medicinal Chemistry|November 4, 2006
Hybrid molecules between distamycin A and active moieties of antitumor agentsPier Giovanni Baraldi, Delia Preti, Francesca Fruttarolo, et al.
Purinergic Signalling|April 30, 2008
Recent improvements in the development of A(2B) adenosine receptor agonistsPier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, Francesca Fruttarolo, et al.
Purinergic Signalling|February 3, 2009
Recent improvements in the development of A(2B) adenosine receptor agonistsPier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, Francesca Fruttarolo, et al.
Future Medicinal Chemistry|July 7, 2015
Current status of A1 adenosine receptor allosteric enhancersRomeo Romagnoli, Pier Giovanni Baraldi, Allan R Moorman, et al.
Bioorganic & Medicinal Chemistry|March 5, 2003
Synthesis and growth inhibition activity of alpha-bromoacrylic heterocyclic and benzoheterocyclic derivatives of distamycin A modified on the amidino moietyPier Giovanni Baraldi, Italo Beria, Paolo Cozzi, et al.
Medicinal Research Reviews|March 31, 2015
History and perspectives of A2A adenosine receptor antagonists as potential therapeutic agentsDelia Preti, Pier Giovanni Baraldi, Allan R Moorman, et al.
European Journal of Medicinal Chemistry|July 5, 2015
Design, synthesis and antiproliferative activity of novel heterobivalent hybrids based on imidazo[2,1-b][1,3,4]thiadiazole and imidazo[2,1-b][1,3]thiazole scaffoldsRomeo Romagnoli, Pier Giovanni Baraldi, Filippo Prencipe, et al.
Mini Reviews in Medicinal Chemistry|January 20, 2009
alpha-halogenoacrylic derivatives of antitumor agentsRomeo Romagnoli, Pier Giovanni Baraldi, Olga Cruz-Lopez, et al.
Chemmedchem|August 12, 2009
alpha-Bromoacrylamido N-substituted isatin derivatives as potent inducers of apoptosis in human myeloid leukemia cellsRomeo Romagnoli, Pier Giovanni Baraldi, Olga Cruz-Lopez, et al.
Journal of Biomedical Science|October 18, 2005
N-Arylpiperazine modified analogues of the P2X7 receptor KN-62 antagonist are potent inducers of apoptosis of human primary osteoclastsLetizia Penolazzi, Ercolina Bianchini, Elisabetta Lambertini, et al.
Pageof 16